Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:57 pm Purchase | 2023-12-31 | 13G | Aura Biosciences, Inc. AURA | Citadel Advisors LLC | 3,631,494 7.400% | 894,441 (+32.68%) | Filing History |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT | Citadel Advisors LLC | 122,948 6.500% | -14,662 (-10.65%) | Filing History |
| 2024-02-14 4:57 pm Purchase | 2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Citadel Advisors LLC | 3,072,587 5.000% | 91,263 (+3.06%) | Filing History |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | Ikena Oncology, Inc. IKNA | Citadel Advisors LLC | 14,848 0.400% | -164,746 (-91.73%) | Filing History |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | Immuneering Corporation IMRX | Citadel Advisors LLC | 2,078,092 7.100% | -63,405 (-2.96%) | Filing History |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | MoonLake Immunotherapeutics MLTX | Citadel Advisors LLC | 2,034,260 3.400% | -851,832 (-29.52%) | Filing History |
| 2024-02-14 4:57 pm Purchase | 2023-12-31 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV | Citadel Advisors LLC | 1,649,664 7.400% | 15,515 (+0.95%) | Filing History |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | Northern Star Investment Corp. II NSTB | Citadel Advisors LLC | 806 0.000% | -50,128 (-98.42%) | Filing History |
| 2024-02-14 4:57 pm Purchase | 2023-12-31 | 13G | Tourmaline Bio, Inc. TRML | Citadel Advisors LLC | 2,265 0.000% | 2,265 (New Position) | Filing History |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | Turtle Beach Corporation TBCH | Citadel Advisors LLC | 223,036 1.300% | -683,735 (-75.40%) | Filing History |
| 2024-02-14 4:57 pm Sale | 2023-12-31 | 13G | Appian Corporation APPN | Citadel Advisors LLC | 1,372,895 3.300% | -584,302 (-29.85%) | Filing History |
| 2024-02-14 4:55 pm Sale | 2023-12-31 | 13G | Forbion European Acquisition Corp. FRBN | Citadel Advisors LLC | 0 0.000% | -1,075,058 (Position Closed) | Filing History |
| 2024-02-14 4:55 pm Sale | 2023-12-31 | 13G | Khosla Ventures Acquisition Co. KVSA | Citadel Advisors LLC | 0 0.000% | -2,705,290 (Position Closed) | Filing History |
| 2024-02-14 4:55 pm Sale | 2023-12-31 | 13G | Acropolis Infrastructure Acquisition Corp. ACRO | Citadel Advisors LLC | 0 0.000% | -2,241,549 (Position Closed) | Filing History |
| 2024-02-14 4:55 pm Sale | 2023-12-31 | 13G | Apollo Strategic Growth Capital II APGB | Citadel Advisors LLC | 0 0.000% | -4,078,643 (Position Closed) | Filing History |
| 2024-02-14 4:55 pm Sale | 2023-12-31 | 13G | Artemis Strategic Investment Corporation ARTE | Citadel Advisors LLC | 0 0.000% | -1,621,525 (Position Closed) | Filing History |
| 2024-02-14 4:55 pm Sale | 2023-12-31 | 13G | Decibel Therapeutics, Inc. DBTX | Citadel Advisors LLC | 0 0.000% | -1,863,411 (Position Closed) | Filing History |
| 2024-01-22 4:04 pm Purchase | 2024-01-12 | 13G | NETSTREIT Corp. NTST | Citadel Advisors LLC | 4,108,199 5.200% | 4,108,199 (New Position) | Filing History |
| 2024-01-02 4:14 pm Purchase | 2023-12-20 | 13G | COMPASS Pathways plc CMPS | Citadel Advisors LLC | 3,195,517 5.000% | 3,195,517 (New Position) | Filing History |
| 2023-12-26 4:47 pm Purchase | 2023-12-15 | 13G | Allurion Technologies Inc. ALUR | Citadel Advisors LLC | 102,285 5.100% | 102,285 (New Position) | Filing History |